<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 6 Issue 2</issue_number>
<issue_period>2015 (April - June)</issue_period>
<title>IN-VIVO ANTICANCER ACTIVITY OF AQUEOUS EXTRACT OF HOLOPTELEA INTEGRIFOLIA LEAVES AGAINST EHRLICH ASCITES CARCINOMA IN SWISS ALBINO MICE. </title>
<abstract>The main aim of the present study is to evaluate an Antitumor activity of Aqueous extract of leaves of  lessThan i greaterThan Holoptelea integrifolia lessThan /i greaterThan  (HIAQ) in EAC induced Ascites tumor model: An In-vivo study. The Aqueous extract of leaves of  lessThan i greaterThan Holoptelea integrifolia lessThan /i greaterThan  was prepared by cold maceration technique. Acute toxicity test was performed using Swiss albino rats before starting the in-vivo anticancer activity, were the MTD was more than 5000mg/kg. The in-vivo Antitumor activity was assessed by administering 250mg and 500mg/kg of Aqueous extract of  lessThan i greaterThan HI lessThan /i greaterThan  leaves, orally for 9 days and Cisplatin (3.5mg/kg, i.p., Single dose). Various parameters like Change in body weight, Mean Survival Time, Percentage Increase in Life Span, Hematological &amp; Biochemical parameters were assessed. All the parameters were considerably restored towards the normal values. The in-vivo activity of  lessThan i greaterThan HI lessThan /i greaterThan  500mg/kg was shown more significant results than 250mg/kg. Hence 500mg/kg was taken for combination study with standard drug Cisplatin.</abstract>
<authors>PRAMOD SG, JAYANTHI MK, MRUTHUNJAYA K, MANJULA SN AND SUNIL KUMAR.</authors>
<keywords>Holoptelea integrifolia, Cisplatin, Aqueous extract, Ehrlich Ascites Carcinoma, Swiss albino mice.</keywords>
<pages>217-225</pages>
</article>
</Journal>
